DDR1 and carcinoma: According to the immunohistochemical scores listed inTable 2, the DDR1 positive rate was 100% (34 of 34) in poorly differentiated carcinoma tissues, 76% (57 of 75) in moderately differentiated, and 29.4% (5 of 17) in highly differentiated carcinoma tissues.